Yupingfeng Formula Exerts Antiviral Property by Promoting IFN‐I Production and IgG1 Antibody Response
Journal of Medical Virology · 2025
DOI: 10.1002/jmv.70723 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Chenglong Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China. Hauptthemen laut MEDLINE: Antiviral Agents, Immunoglobulin G, Drugs, Chinese Herbal, Orthomyxoviridae Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: This study was supported by the Natural Science Foundation of Shandong Province, China (ZR2024QH110), the National Natural Science Foundation of China (8210413….
Abstract (Originalsprache)
Yupingfeng (YPF) is a classic formula of traditional Chinese medicine and has been widely used to prevent and treat respiratory virus infectious diseases. However, the pharmacological mechanism underlying the antiviral activity of YPF remains elusive. In the present study, we evaluated the ability of YPF to promote type I interferon (IFN‐I) production in vitro, subsequently inducing expression of numerous interferon‐stimulated genes that exert antiviral activities. In addition, by employing an advanced bioluminescence imaging‐based mouse model of influenza virus infection, we monitored the alteration of viral kinetics in vivo upon YPF treatment in real time. As a result, our findings demonstrated that YPF predominantly reduces the viral load in animals at later stages of infection. Further mechanistic studies suggested that YPF can especially enhance the Th2 polarization and IgG1 antibody response, accelerating the elimination of invading viruses. Our study provides consolidated evidence for the antiviral properties of YPF and will facilitate its clinical use and further development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China.
- Qingdao Academy of Chinese Medical Sciences, Shandong University of Traditional Chinese Medicine, Qingdao, China.
- State Key Laboratory of Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Jiangsu Kanion Pharmaceutical Co. Ltd., Nanjing, China.
- Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
ORCID-Profile: Ruikun Du
Förderung
- This study was supported by the Natural Science Foundation of Shandong Province, China (ZR2024QH110), the National Natural Science Foundation of China (8210413…
Zitieren
APA
Chen, C., Zhu, M., Li, Y., Jiang, J., Ma, J., Fan, L., Zhao, J., Ma, J., Jiang, R., Cui, Q., Rong, L., & Du, R. (2025). Yupingfeng Formula Exerts Antiviral Property by Promoting IFN‐I Production and IgG1 Antibody Response. Journal of Medical Virology. https://doi.org/10.1002/jmv.70723
Vancouver
Chen C, Zhu M, Li Y, Jiang J, Ma J, Fan L, et al. Yupingfeng Formula Exerts Antiviral Property by Promoting IFN‐I Production and IgG1 Antibody Response. Journal of Medical Virology. 2025. doi:10.1002/jmv.70723
BibTeX
@article{Chen2025,
author = {Chen, Chenglong and Zhu, Murong and Li, Yanan and Jiang, Jiayu and Ma, Jing and Fan, Lingyuan and Zhao, Jiarong and Ma, Jingjing and Jiang, Ruijie and Cui, Qinghua and Rong, Lijun and Du, Ruikun},
title = {Yupingfeng Formula Exerts Antiviral Property by Promoting IFN‐I Production and IgG1 Antibody Response},
journal = {Journal of Medical Virology},
year = {2025},
doi = {10.1002/jmv.70723}
}
EUVIMED